The significance of antiphospholipid antibodies tests

Kotaro Otomo, Tatsuya Atsumi

Research output: Contribution to journalReview article

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disease defined by the presence of antiphospholipid antibodies (APL) in plasma of patients with thrombosis and/or pregnancy morbidity. In the classification criteria of APS, the presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL) or anti-β2-glycoprotein I antibodies (aβ2GPI) is necessary to diagnose APS. Recently, we defined "antiphospholipid score (aPL-S)" and evaluate the predictive value for thrombosis. In the study, aPL-S may be a predictive marker for developing thrombosis in patients with autoimmune diseases. In this article, we explain various APL assays for diagnosing APS in a clinical practice, introduce the study of "aPL-S", and discuss the significance of APL tests not only for a diagnosis of APS but also for a predictive marker of thrombosis in patients with autoimmune diseases.

Original languageEnglish
Pages (from-to)63-70
Number of pages8
JournalJapanese Journal of Clinical Immunology
Volume36
Issue number2
DOIs
Publication statusPublished - 2013 Jan 1
Externally publishedYes

Fingerprint

Antiphospholipid Antibodies
Antiphospholipid Syndrome
Thrombosis
Autoimmune Diseases
Lupus Coagulation Inhibitor
Anticardiolipin Antibodies
Glycoproteins
Morbidity
Pregnancy
Antibodies

Keywords

  • Antiphospholipid antibody
  • Antiphospholipid score
  • Antiphospholipid syndrome
  • Sapporo criteria
  • Thrombosis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The significance of antiphospholipid antibodies tests. / Otomo, Kotaro; Atsumi, Tatsuya.

In: Japanese Journal of Clinical Immunology, Vol. 36, No. 2, 01.01.2013, p. 63-70.

Research output: Contribution to journalReview article

@article{0834f3bce84145da8fc8add8f3baf759,
title = "The significance of antiphospholipid antibodies tests",
abstract = "Antiphospholipid syndrome (APS) is an autoimmune disease defined by the presence of antiphospholipid antibodies (APL) in plasma of patients with thrombosis and/or pregnancy morbidity. In the classification criteria of APS, the presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL) or anti-β2-glycoprotein I antibodies (aβ2GPI) is necessary to diagnose APS. Recently, we defined {"}antiphospholipid score (aPL-S){"} and evaluate the predictive value for thrombosis. In the study, aPL-S may be a predictive marker for developing thrombosis in patients with autoimmune diseases. In this article, we explain various APL assays for diagnosing APS in a clinical practice, introduce the study of {"}aPL-S{"}, and discuss the significance of APL tests not only for a diagnosis of APS but also for a predictive marker of thrombosis in patients with autoimmune diseases.",
keywords = "Antiphospholipid antibody, Antiphospholipid score, Antiphospholipid syndrome, Sapporo criteria, Thrombosis",
author = "Kotaro Otomo and Tatsuya Atsumi",
year = "2013",
month = "1",
day = "1",
doi = "10.2177/jsci.36.63",
language = "English",
volume = "36",
pages = "63--70",
journal = "Immunological Medicine",
issn = "0911-4300",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - The significance of antiphospholipid antibodies tests

AU - Otomo, Kotaro

AU - Atsumi, Tatsuya

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Antiphospholipid syndrome (APS) is an autoimmune disease defined by the presence of antiphospholipid antibodies (APL) in plasma of patients with thrombosis and/or pregnancy morbidity. In the classification criteria of APS, the presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL) or anti-β2-glycoprotein I antibodies (aβ2GPI) is necessary to diagnose APS. Recently, we defined "antiphospholipid score (aPL-S)" and evaluate the predictive value for thrombosis. In the study, aPL-S may be a predictive marker for developing thrombosis in patients with autoimmune diseases. In this article, we explain various APL assays for diagnosing APS in a clinical practice, introduce the study of "aPL-S", and discuss the significance of APL tests not only for a diagnosis of APS but also for a predictive marker of thrombosis in patients with autoimmune diseases.

AB - Antiphospholipid syndrome (APS) is an autoimmune disease defined by the presence of antiphospholipid antibodies (APL) in plasma of patients with thrombosis and/or pregnancy morbidity. In the classification criteria of APS, the presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL) or anti-β2-glycoprotein I antibodies (aβ2GPI) is necessary to diagnose APS. Recently, we defined "antiphospholipid score (aPL-S)" and evaluate the predictive value for thrombosis. In the study, aPL-S may be a predictive marker for developing thrombosis in patients with autoimmune diseases. In this article, we explain various APL assays for diagnosing APS in a clinical practice, introduce the study of "aPL-S", and discuss the significance of APL tests not only for a diagnosis of APS but also for a predictive marker of thrombosis in patients with autoimmune diseases.

KW - Antiphospholipid antibody

KW - Antiphospholipid score

KW - Antiphospholipid syndrome

KW - Sapporo criteria

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84940306624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940306624&partnerID=8YFLogxK

U2 - 10.2177/jsci.36.63

DO - 10.2177/jsci.36.63

M3 - Review article

AN - SCOPUS:84940306624

VL - 36

SP - 63

EP - 70

JO - Immunological Medicine

JF - Immunological Medicine

SN - 0911-4300

IS - 2

ER -